PodcastsCiênciaHematologic Oncology Update

Hematologic Oncology Update

Dr. Neil Love
Hematologic Oncology Update
Último episódio

138 episódios

  • Hematologic Oncology Update

    Acute Myeloid Leukemia — Year in Review Series on Relevant New Datasets and Advances

    20/04/2026 | 58min
    Dr Amir Fathi from Massachusetts General Hospital in Boston, Massachusetts, and Dr Eunice S Wang from Roswell Park Comprehensive Cancer Center in Buffalo, New York, discuss key clinical trial data surrounding the use of menin inhibitors in the management of AML.
    CME information and select publications here.
  • Hematologic Oncology Update

    CELMoDs for Multiple Myeloma — Microlearning Activity 2 with Dr Paul G Richardson

    10/04/2026 | 24min
    Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.
    CME information and select publications here.
  • Hematologic Oncology Update

    Immune Thrombocytopenia — Microlearning Activity 4 with Dr Hanny Al-Samkari: ASH 2025 Review

    01/04/2026 | 24min
    Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.
    CME information and select publications here.
  • Hematologic Oncology Update

    CELMoDs for Multiple Myeloma — Microlearning Activity 1 with Dr Paul G Richardson

    23/03/2026 | 24min
    Dr Paul G Richardson from the Dana-Farber Cancer Institute in Boston, Massachusetts, discusses how CELMoDs function, available data with these agents and their possible future role in the treatment of multiple myeloma.
    CME information and select publications here.
  • Hematologic Oncology Update

    Immune Thrombocytopenia — Microlearning Activity 3 with Dr Hanny Al-Samkari: ASH 2025 Review

    21/03/2026 | 29min
    Dr Hanny Al-Samkari from Massachusetts General Hospital in Boston discusses recent developments from the ASH 2025 Annual Meeting involving the use of Bruton tyrosine kinase inhibitors and BAFF-R antagonists in the treatment of immune thrombocytopenia.
    CME information and select publications here.
Mais podcasts de Ciência
Sobre Hematologic Oncology Update
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
Sítio Web de podcast

Ouve Hematologic Oncology Update, Unexplainable e muitos outros podcasts de todo o mundo com a aplicação radio.pt

Obtenha a aplicação gratuita radio.pt

  • Guardar rádios e podcasts favoritos
  • Transmissão via Wi-Fi ou Bluetooth
  • Carplay & Android Audo compatìvel
  • E ainda mais funções
Hematologic Oncology Update: Podcast do grupo
  • Podcast Oncology Today with Dr Neil Love
    Oncology Today with Dr Neil Love
    Ciência, Ensino, Medicina, Saúde e fitness